Prognostic Score and Benefit from Abiraterone in First-line Metastatic, Castration-resistant Prostate Cancer Citation: Lorente D, Llacer C, Lozano R, et al. European Urology. 2021. doi: https://doi.org/10.1016/j.eururo.2021.07.014
The YODA Project